Cargando…
TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway
Pancreatic cancer is one of the major reasons of cancer-associated deaths due to poor diagnosis, high metastasis and drug resistance. Therefore, it is important to understand the cellular and molecular mechanisms of pancreatic cancer to identify new targets for the treatment. TIPE2 is an essential r...
Autores principales: | Feng, Fang, Liu, Chunliang, Bian, Huahui, Cai, Wei, Zhou, Ying, Zhou, Li, Zhuang, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260882/ https://www.ncbi.nlm.nih.gov/pubmed/34249724 http://dx.doi.org/10.3389/fonc.2021.680985 |
Ejemplares similares
-
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
por: Zhu, Linan, et al.
Publicado: (2018) -
TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC
por: Zhong, Mengya, et al.
Publicado: (2021) -
TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis
por: Hu, Wei, et al.
Publicado: (2019) -
TIPE2 Inhibits Hypoxia-Induced Wnt/β-Catenin Pathway Activation and EMT in Glioma Cells
por: Liu, Zhi-jun, et al.
Publicado: (2016) -
Mysteries of TGF-β Paradox in Benign and Malignant Cells
por: Zhang, Qiang, et al.
Publicado: (2014)